Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : TAK crawled date : 2021 - 11 - 09 save search
Selecta Biosciences Reports Third Quarter 2021 Financial Results and Provides Business Update
Published: 2021-11-09 (Crawled : 16:00) - globenewswire.com
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: 0.28%
H: 0.0%
C: 0.0%
SELB 4 | $0.8812 -8.0% 2.12% 0
|
Health Technology
|
| O: -2.02%
H: 0.0%
C: 0.0%
financial results results
Exelixis Announces Enrollment Completion in Phase 3 CONTACT-01 Pivotal Trial of Cabozantinib in Combination with an Immune Checkpoint Inhibitor in Previously Treated Metastatic Non-Small Cell Lung Cancer
Published: 2021-11-09 (Crawled : 15:15) - biospace.com/
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: 0.28%
H: 0.0%
C: 0.0%
EXEL | $22.51 0.09% 0.09% 2.3M
|
Health Technology
|
| O: -0.69%
H: 0.83%
C: -1.02%
lung cancer cancer phase 3 trial enroll
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
WLGS | $0.59 18.0% 17.9% 2.3M
|
UONE | $2.36 19.8% 16.53% 75K
|
Consumer Services
RWOD | $9.54 19.3% 16.18% 6.1M
|
n/a
BSFC | $0.0758 17.7% 15.04% 92M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.